Alongside immunotherapy or chemo, the wearable device helped patients live longer in a trial, though the results are somewhat controversial.

All cancer mutations that cause drug resistance fall into one of four categories. New research has detailed each type, ...

Northwestern Medicine scientists have discovered how a protein in a deadly type of lung cancer can control how the immune ...

Adding a six-week course of chemotherapy to the standard course of treatment for locally advanced cervical cancer resulted in ...

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) has approved Optune Lua® for ...

Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it ...

Antibody-drug conjugates (ADCs) combine antibodies with cytotoxic drugs to target cancer cells while minimizing damage to ...

There are no approved therapies to tackle c-Met protein overexpression, AbbVie said in a press release. C-Met is a receptor ...

In a breakthrough for cancer research, Medgnosis has leveraged its state-of-the-art generative AI (GenAI) system to transform drug discovery. This GenAI targets both druggable and undruggable proteins ...

Hilmar Warenius on how his discovery of a new type of cancer treatment could be well on its way to revolutionising the ...